October 13, 2008 — Data from an independent meta-analysis of Abbott Vascular’s SPIRIT II and SPIRIT III randomized clinical trials demonstrated that the XIENCE V Everolimus Eluting Coronary Stent System continues to deliver clinically significant benefits for patients compared to the TAXUS paclitaxeleluting coronary stent system out to two years, said Abbott.

October 14, 2008 – Medtronic released, at TCT 2008, new data from the ENDEAVOR clinical program that reinforces the consistently strong performance of the company’s Endeavor drug-eluting stent (DES) across diverse patient populations affected by coronary artery disease.

One-year results from the ENDEAVOR-Five registry – including those for subsets of diabetics and patients with acute myocardial infarction (AMI) – demonstrate that the Endeavor DES performs comparably in a real-world population of patients with complex disease and in specific patient subsets.

October 13, 2008 – Piedmont Hospital in Atlanta, GA, is installing the Aquilion ONE from Toshiba America Medical Systems in an effort to streamline the series of diagnostic tests that patients with heart conditions or stroke undergo.

With the Aquilion ONE, a dynamic volume CT system, physicians can reportedly provide one comprehensive exam, reduce cost by eliminating multiple tests and access complete information to diagnose and treat patients faster.

October 13, 2008 – GE Healthcare is featuring real-time imaging solutions made possible, in part, by new collaborative partnerships, at TCT 2008

The GE Innova cardiovascular X-ray system will soon be aided by the new Innova Dose, Innova 3D and Innova with Stent Technologies features. GE’s Innova Dose package aims to deliver superb image quality and custom dose management.